Subscribe to Newsletter

Trends & Forecasts

Discovery & Development Business Practice

In Conversation with Franco Negron of Patheon at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Franco Negron from Patheon
Discovery & Development Business Practice

In Conversation with Andreas Gryczke of BASF at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Andreas Gryczke from BASF
Discovery & Development Business Practice

In Conversation with Matthias Bucerius of Merck KGaA at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Dr Matthias Bucerius from Merck KGaA
Discovery & Development Business Practice

In Conversation with Bernhard Paul of Johnson Matthey at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Bernhard Paul from Johnson Matthey
Discovery & Development Business Practice

In Conversation with Gary Lord of Dow Corning Healthcare at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Gary Lord from Dow Corning Healthcare
Discovery & Development Business Practice

In Conversation with Simon Edwards of Cambrex at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Simon Edwards from Cambrex
Discovery & Development Business Practice

In Conversation with Dr Jean Luc Herbeaux of Evonik at CPhI Worldwide 2016

The Medicine Maker's Charlotte Barker speaks with Dr Jean Luc Herbeaux from Evonik
Manufacture Business Practice

Direct visualization, sizing and concentration measurements of drug delivery nanoparticles

In this application note, we discuss how Nanoparticle Tracking Analysis (NTA) is used to measure the size and concentration of nanoparticles used for drug delivery, such as liposomes, in order to determine efficacy and rate of uptake, degradation and clearance from the body.

Discovery & Development Business Practice

In-vitro bioequivalence studies

The Morphologi G3-ID can be used to compare the Active Pharmaceutical Ingredients (API) within oral solid dose formualtions. Here we apply it to comparing innovator and generic versions of a product containing two APIs.
Business & Regulation Business Practice

Accessing Big Pharma’s Conscience

| Jayasree K. Iyer

Sitting Down With... Jayasree K. Iyer, Executive Director, Access to Medicine Foundation
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

December Issue of The Medicine Maker